Centessa Pharmaceuticals (CNTA) Tax Provisions (2021 - 2026)
Centessa Pharmaceuticals (CNTA) reported Tax Provisions of $850000.0 for Q1 2026, down 39.16% year-over-year from $1.4 million in Q1 2025, and up 262.84% quarter-over-quarter from -$522000.0 in Q4 2025.
Centessa Pharmaceuticals (CNTA) Tax Provisions (2021 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 6 years of Tax Provisions data on file, last reported at $850000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $850000.0, down 39.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 66.17% YoY), and the FY2025 annual result was $1.8 million, down 36.04% from the prior year.
- Tax Provisions rose to $850000.0 in Q1 2026 per CNTA's latest filing, from -$522000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $1.4 million in Q1 2025 and troughed at -$24.1 million in Q2 2023.
- A 5-year average of -$1.2 million and a median of $481000.0 in 2024 frame the typical range for Tax Provisions.
- On a YoY basis, Tax Provisions climbed as much as 746.25% in 2023 and fell as far as 109222.73% in 2023.
- A 5-year view of Tax Provisions shows it stood at -$664000.0 in 2022, then soared by 272.29% to $1.1 million in 2023, then decreased by 8.22% to $1.0 million in 2024, then plunged by 149.71% to -$522000.0 in 2025, then surged by 262.84% to $850000.0 in 2026.
- Business Quant data shows CNTA's Tax Provisions at $850000.0 in Q1 2026, -$522000.0 in Q4 2025, and $166000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Centessa Pharmaceuticals | 6.15 Bn | 6.15 Bn | - | 850,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 850,000.00 |
| Dec 31, 2025 | -522,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 778,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 608,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 481,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | -2.83 Mn |
| Jun 30, 2023 | -24.05 Mn |
| Mar 31, 2023 | 677,000.00 |
| Dec 31, 2022 | -664,000.00 |
| Sep 30, 2022 | -100,000.00 |
| Jun 30, 2022 | -22,000.00 |
| Mar 31, 2022 | 80,000.00 |
| Dec 31, 2021 | 114,000.00 |